Opium may affect coronary artery disease by inducing inflammation but not through the expression of CD9, CD36, and

Mohammad Amin Momeni-Moghaddam1,2, Gholamreza Asadikaram2,3, Mohammad Masoumi4

  • 1Department of Nutrition and Biochemistry, Gonabad University of Medical Sciences, Gonabad, Iran.

Insights

Opium addiction did not alter scavenger receptor expression in coronary artery disease (CAD) patients. However, opium use was linked to increased inflammation via tumor necrosis factor-alpha (TNF-α) and malondialdehyde (MDA) in CAD.

Area of Science:

  • Cardiovascular Science
  • Pharmacology
  • Immunology

Background:

  • Coronary artery disease (CAD) mechanisms are complex and not fully understood.
  • The impact of opium on CAD pathogenesis, particularly regarding inflammatory markers and scavenger receptors, requires investigation.

Purpose of the Study:

  • To investigate the effect of opium addiction on scavenger receptor expression (CD36, CD68, CD9) in monocytes.
  • To evaluate plasma levels of tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), malondialdehyde (MDA), and nitric oxide metabolites (NOx) in CAD patients with and without opium addiction.

Main Methods:

  • Case-control study involving three groups: opium-addicted CAD patients, non-addicted CAD patients, and controls.
  • Quantitative polymerase chain reaction (RT-qPCR) and flow cytometry used to assess gene and protein expression of CD9, CD36, and CD68.
  • Plasma levels of TNF-α, IFN-γ, MDA, and NOx were measured.

Main Results:

  • Opium-addicted CAD patients showed significantly higher plasma levels of TNF-α compared to both non-addicted CAD patients and controls.
  • Malondialdehyde (MDA) levels were significantly elevated in both CAD groups versus controls.
  • No significant differences were observed in the expression of CD9, CD36, CD68, IFN-γ, or NOx across the three groups.

Conclusions:

  • Opium addiction does not appear to significantly affect the gene or protein expression of CD36, CD68, and CD9 in CAD patients.
  • Opium may contribute to CAD development through inflammatory pathways independent of these specific scavenger receptors, evidenced by elevated TNF-α.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
22
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
44
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
711
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
19
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
23